Samjin Pharm (005500) — Cash Flow-to-Debt Ratio
Samjin Pharm (005500) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of ₩-1.43 Billion could theoretically repay 0% of its total liabilities (₩184.63 Billion) in one year. See Samjin Pharm free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Samjin Pharm Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Samjin Pharm across 12 annual periods. Also explore 005500 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Samjin Pharm (2013–2024)
Year-by-year debt coverage analysis for Samjin Pharm. For market capitalisation and broader financial context, see Samjin Pharm (005500) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | ₩38.15 Billion | ₩163.51 Billion | ▲ +332.7% |
| 2023 | 0.05x | ₩8.33 Billion | ₩154.54 Billion | ▼ -59.2% |
| 2022 | 0.13x | ₩17.29 Billion | ₩130.69 Billion | ▼ -45.7% |
| 2021 | 0.24x | ₩23.97 Billion | ₩98.33 Billion | ▼ -43.2% |
| 2020 | 0.43x | ₩23.86 Billion | ₩55.58 Billion | ▼ -15.2% |
| 2019 | 0.51x | ₩23.63 Billion | ₩46.68 Billion | ▼ -24.3% |
| 2018 | 0.67x | ₩30.08 Billion | ₩44.95 Billion | ▼ -13.2% |
| 2017 | 0.77x | ₩37.28 Billion | ₩48.38 Billion | ▼ -8.3% |
| 2016 | 0.84x | ₩48.66 Billion | ₩57.88 Billion | ▲ +222.6% |
| 2015 | 0.26x | ₩18.94 Billion | ₩72.67 Billion | ▼ -33.1% |
| 2014 | 0.39x | ₩32.41 Billion | ₩83.26 Billion | ▲ +380.1% |
| 2013 | 0.08x | ₩7.37 Billion | ₩90.96 Billion | — |